KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) FCF Margin (2018 - 2025)

Historic FCF Margin for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to 33.55%.

  • Twist Bioscience's FCF Margin fell 68400.0% to 33.55% in Q4 2025 from the same period last year, while for Dec 2025 it was 22.15%, marking a year-over-year decrease of 14400.0%. This contributed to the annual value of 20.08% for FY2025, which is 20200.0% up from last year.
  • As of Q4 2025, Twist Bioscience's FCF Margin stood at 33.55%, which was down 68400.0% from 24.48% recorded in Q3 2025.
  • Over the past 5 years, Twist Bioscience's FCF Margin peaked at 9.01% during Q2 2024, and registered a low of 154.4% during Q1 2022.
  • Over the past 5 years, Twist Bioscience's median FCF Margin value was 34.37% (recorded in 2023), while the average stood at 63.56%.
  • As far as peak fluctuations go, Twist Bioscience's FCF Margin soared by 2126300bps in 2021, and later tumbled by -488100bps in 2022.
  • Quarter analysis of 5 years shows Twist Bioscience's FCF Margin stood at 141.45% in 2021, then rose by 14bps to 121.48% in 2022, then skyrocketed by 72bps to 34.24% in 2023, then increased by 22bps to 26.71% in 2024, then fell by -26bps to 33.55% in 2025.
  • Its last three reported values are 33.55% in Q4 2025, 24.48% for Q3 2025, and 11.0% during Q2 2025.